Zhu, H., Du, S., Yang, Q., Xu, L., & Shi, W. (2026). A Fivefold Maximum Drug-Likeness Strategy for Prioritizing Antibacterial Candidates Against Escherichia coli. Pharmaceuticals (14248247), 19(5), 744. https://doi.org/10.3390/ph19050744
Chicago Style (17th ed.) CitationZhu, Haoyu, Shijie Du, Qin Yang, Lu Xu, and Wei Shi. "A Fivefold Maximum Drug-Likeness Strategy for Prioritizing Antibacterial Candidates Against Escherichia Coli." Pharmaceuticals (14248247) 19, no. 5 (2026): 744. https://doi.org/10.3390/ph19050744.
MLA (9th ed.) CitationZhu, Haoyu, et al. "A Fivefold Maximum Drug-Likeness Strategy for Prioritizing Antibacterial Candidates Against Escherichia Coli." Pharmaceuticals (14248247), vol. 19, no. 5, 2026, p. 744, https://doi.org/10.3390/ph19050744.